BioLife Solutions BLFS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $1.95M-56.6% | $2.25M-56.3% | $2.93M-48.5% | $3.7M-40.4% | $4.48M-33.7% | ||
| $23.65M-18.2% | $22.99M-25.6% | $26.61M-11.7% | $26.03M-23.3% | $28.89M-9.9% | ||
| $68K— | $65K— | —— | —— | —— | ||
| $4.84M+52.7% | -$264K-108% | $2.91M+172% | $2.13M+133% | $3.17M+127% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.15M— | ||
| —— | —— | —— | —— | —— | ||
| $274K— | $264K— | —— | —— | —— | ||
| -$1.83M-38.7% | -$2.01M-107% | -$709K+20.2% | -$1.21M-5,142% | -$1.32M-257% | ||
| $17.9M+22.3% | $20.12M+139% | $16.84M— | $15.54M— | $14.63M— | ||
| $9.56M+167% | $9.56M+179% | $3.67M+186% | $3.31M+18.9% | $3.58M+15.1% | ||
| $104.17M+146% | $114.06M+519% | $79.79M+291% | $72.01M+226% | $42.37M+67.7% | ||
| $8.59M+175% | $6.83M+94.1% | $4.5M+44.8% | $3.48M+2.2% | $3.12M-20.4% | ||
| —— | $23.52M-68.0% | $35.99M-34.6% | $48.47M+32.0% | $60.95M+232% | ||
| —— | $0-100% | $75K-66.7% | $150K0.0% | $225K+200% | ||
| -$47.33M-251% | -$72.68M-225% | $961K+108% | $5.25M+165% | $31.35M+113% | ||
| $190K— | $0— | -$119K-101% | -$73K-101% | $0-100% | ||
| —— | —— | —— | —— | —— | ||
| $26K— | $33K— | -$29K— | —— | —— | ||
| -$15.83M-79.4% | -$10.92M-61.0% | -$12.51M-275% | -$11M-225% | -$8.82M-186% | ||
| -$47.68M-228% | -$65.91M-210% | $5.29M+8.8% | $9.79M+1,357% | $37.16M+250% | ||
| $570K-60.1% | $762K-52.6% | $1.02M-42.6% | $1.26M-30.9% | $1.43M-23.8% | ||
| $753K+89.7% | $736K+55.3% | $602K-2.9% | $461K-45.1% | $397K-62.3% | ||
| $2.06M-37.5% | $2.43M-30.5% | $2.88M-21.2% | $3.09M-24.6% | $3.29M— | ||
| -$323K+41.9% | -$510K+10.1% | -$619K-1.6% | -$575K+3.0% | -$556K+3.1% | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| —— | $10.32M-35.0% | $11.71M-1.6% | $13.1M+65.0% | $14.49M+265% | ||
| —— | —— | —— | —— | —— | ||
| -$1.83M-38.7% | -$2.01M-107% | -$709K+20.2% | -$1.21M-5,142% | -$1.32M-257% | ||
| $2K-100.0% | $3.04M+26.3% | $6.5M+341% | $4.9M+216% | $4.62M+347% | ||
| —— | $1.88M+342% | $1.51M+261% | $1.15M+178% | $786.75K+92.4% | ||
| —— | —— | —— | —— | —— | ||
| $48.2M+213% | $34.76M+88.9% | $22.15M-14.3% | $15.54M-50.5% | $15.4M-64.8% | ||
| $636K-65.7% | $886K-57.2% | $825K-76.0% | $886K-77.3% | $1.85M-57.1% | ||
| —— | $0-100% | $75K-66.7% | $150K0.0% | $225K+200% | ||
| $8.59M+175% | $6.83M+94.1% | $4.5M+44.8% | $3.48M+2.2% | $3.12M-20.4% | ||
| $26K— | $33K— | -$29K— | —— | —— | ||
| $473K-78.2% | $975K-59.3% | $1.64M-32.8% | $2.06M-44.7% | $2.17M-13.9% | ||
| $10M+33.3% | $10M+100% | $10M+288% | $10M+6,567% | $7.5M+3,233% | ||
| -$494K— | $0— | $460K— | —— | —— | ||
| -$135K— | $108K— | —— | —— | —— | ||
| —— | $0— | $0-100% | $0-100% | $0-100% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioLife Solutions generate?
- BioLife Solutions (BLFS) generated $17.9M in operating cash flow over the trailing twelve months.
- What is BioLife Solutions's free cash flow?
- After $9.6M of capital expenditures, BioLife Solutions's free cash flow was $14.1M over the trailing twelve months, up 110.7% year over year.
- Where does BioLife Solutions's cash flow data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
